Today marks the start of a series of dissemination webinars covering different modules of the Paediatric ARV Working Group (PAWG) toolkit.
Join one of the dissemination webinars covering different modules of the toolkit:
2. Acceptability / Target product profile / Product commercialization – 16 October, 14:00-15:30 CET – Register here
3. Regulatory filing / Pharmacovigilance – 8 November, 14:00-15:30 CET – Register here
4. Community engagement – 16 November, 14:00-15:30 CET – Register here
5. Pregnant and breastfeeding women – 30 November, 14:00-15:30 CET – Register here
More information at GAP-f events webpage, where the webinar recording and slide sets will also be available.
Various efforts have enabled better alignment and convergence around key principles in paediatric drug development. These principles now need to be crystallised and promoted, so that higher standards in paediatric drug research and development can be ensured. The toolkit was initiated by the WHO and Unitaid incollaboration with, IMPAACT, PENTA and the WHO convened Paediatric ARV Working Group (PAWG). The toolkit identifies the challenges and outlines possible solutions for promoting and accelerating timely and high-quality research and development of antiretroviral drug formulations suitable for infants, children, adolescents, and pregnant and breastfeeding women.